Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 9.24B P/E 40.55 EPS this Y 29.10% Ern Qtrly Grth 41.50%
Income 163.5M Forward P/E 50.85 EPS next Y 24.30% 50D Avg Chg -10.00%
Sales 787.97M PEG 2.66 EPS past 5Y - 200D Avg Chg 4.00%
Dividend N/A Price/Book 16.17 EPS next 5Y 25.00% 52W High Chg -21.00%
Recommedations 2.90 Quick Ratio 12.50 Shares Outstanding 37.54M 52W Low Chg 46.00%
Insider Own 1.19% ROA 8.68% Shares Float 36.95M Beta 0.88
Inst Own 96.50% ROE 24.73% Shares Shorted/Prior 1.47M/1.79M Price 252.23
Gross Margin 86.99% Profit Margin 20.75% Avg. Volume 563,770 Target Price 328.64
Oper. Margin 19.38% Earnings Date Aug 5 Volume 408,157 Change -2.90%
About ShockWave Medical, Inc.

Shockwave Medical, Inc., a medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters used in IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter used for IVL System in large diameter vessels. It also provides product for the treatment of coronary artery disease, such as C2 IVL catheter and C2+IVL catheter that are two-emitter catheters for use in IVL system; and Reducer, a device to treat refractory angina. In addition, the company develops COSIRA-II trial; shockwave C2 Aero, a coronary IVL catheter; shockwave javelin coronary, a non-balloon-based catheter platform to treat of tight, difficult-to-cross coronary lesions; shockwave L6; shockwave E8 catheter, to target long peripheral artery lesions; shockwave javelin peripheral, a non-balloon-based catheter platform, to treat tight, difficult-to-cross peripheral lesions. Further, it offers shockwave carotid IVL, a purpose-built IVL System to treat calcified carotid artery lesions; and Shockwave Crescendo, a platform developed to treat calcified, stenotic heart valves. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.

ShockWave Medical, Inc. News
05/07/24 Shockwave Medical (SWAV) Q1 Earnings Beat, Revenues Rise Y/Y
05/07/24 Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
05/07/24 Beyond the Balance Sheet: What SWOT Reveals About Shockwave Medical Inc (SWAV)
05/06/24 Shockwave Medical (SWAV) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
05/06/24 Shockwave Medical (SWAV) Q1 Earnings and Revenues Top Estimates
05/06/24 Shockwave Medical Surpasses Analyst Revenue Forecasts in Q1 2024
05/06/24 Shockwave Medical Reports First Quarter 2024 Financial Results
05/06/24 Shockwave Medical (SWAV) Earnings Expected to Grow: What to Know Ahead of Q1 Release
04/25/24 Why the Market Dipped But Shockwave Medical (SWAV) Gained Today
04/24/24 Shockwave Medical (SWAV) Rose on an Acquisition News and Solid Financial Result
04/23/24 Why Investors Need to Take Advantage of These 2 Medical Stocks Now
04/21/24 11 Best Low Price Pharma Stocks To Invest In
04/19/24 Shockwave Medical (SWAV) Advances While Market Declines: Some Information for Investors
04/16/24 Johnson & Johnson Shows Focus On Strengthening Its Business Upon Its Consumer Health Unit Spinoff
04/16/24 J&J CFO on Q1 Earnings, Forecast and Product Pipeline
04/16/24 ‘We think in decades’: J&J’s $30B spending spree may not be over
04/15/24 Why Shockwave Medical (SWAV) Could Beat Earnings Estimates Again
04/12/24 Pharma Stock Roundup: JNJ to Buy Shockwave Medical, Other Pipeline & Regulatory News
04/12/24 Shockwave Medical (SWAV) Rose on Strong Financial Results
04/10/24 Wall Street Favorites: 3 Dividend Stocks With Strong Buy Ratings for April 2024
SWAV Chatroom

User Image StockInvest_us Posted - 4 days ago

Signal alert: $SWAV - Oversold Trend Short (Undervalued) https://stockinvest.us/l/XWWGQqdFpJ

User Image Fab0862 Posted - 4 days ago

$SWAV why there is no activity in the options trading?

User Image Camarojunky67 Posted - 5 days ago

$SWAV vote no further merger if you received any proxy voting

User Image TJmaximus Posted - 6 days ago

$SWAV My price target set several years ago was for $573, I would have seen it had it not been for the JNJ interception… what a glorious ride.

User Image intratio Posted - 6 days ago

Our predictive algorithm assessed this company s stock price will plummet quickly and dramatically with a very negative long-term outlook $SWAV

User Image Estimize Posted - 6 days ago

$SWAV beats the Estimize EPS Consensus by 43c and the Estimize Revenue Consensus by $10.22M. Reports FQ1 earnings of $1.44 EPS and $218... http://www.estimize.com/swav/fq1-2024?utm_content=beat_or_miss&utm_medium=tweet&utm_source=stocktwits

User Image TJmaximus Posted - 6 days ago

$SWAV JNJ got a steal.

User Image TJmaximus Posted - 6 days ago

$SWAV https://seekingalpha.com/news/4100716-shockwave-medical-gaap-eps-of-1_44-beats-0_47-revenue-of-218_8m-beats-11_15m

User Image GPKM Posted - 6 days ago

$SWAV Why its not moving in any direction ?

User Image DonCorleone77 Posted - 6 days ago

$SWAV $JNJ ShockWave Medical reports Q1 diluted EPS $1.44, consensus 98c Reports Q1 revenue $218.8M, consensus $207.69M. Given the proposed acquisition of Shockwave Medical by Johnson & Johnson (JNJ), Shockwave Medical is withdrawing its FY24 guidance, previously issued on February 15. "The solid growth in the first quarter across geographies and products is a testament to the continued demand for our innovative solutions, driven by the unrelenting and extraordinary performance of our global Shockwave teams," said Doug Godshall, CEO of Shockwave Medical. "Our team is looking forward to continuing our mission as part of Johnson & Johnson and to working together to bring our life-changing therapies to even more patients across the globe."

User Image TJmaximus Posted - 6 days ago

$SWAV Just another beat... $335

User Image epsguid Posted - 6 days ago

$SWAV reported earnings of $1.44, consensus was $1.04 via @eWhispers #epsbeat http://eps.sh/d/swav

User Image Stock_Titan Posted - 6 days ago

$SWAV Shockwave Medical Reports First Quarter 2024 Financial Results https://www.stocktitan.net/news/SWAV/shockwave-medical-reports-first-quarter-2024-financial-618ib8f93qs9.html

User Image AivelX Posted - 6 days ago

💡 #AivelX After-Hours Earnings Insights (3/3) $SWAV - Ref.Earnings: 1918 Next Day: 65% new high (max 41.3%) vs 29% new low (max -23.4%) 5 Days Later: 76% new highs, 45% new lows Same Week: 7% broke 303 (-8%) $SYM - Ref.Earnings: 118 Next Day: 58% new high (max 17.8%) vs 32% new low (max -13.3%) 5 Days Later: 73% new highs, 45% new lows Same Week: 37% broke 45 (+5%) $TDC - Ref.Earnings: 95 Next Day: 68% new high (max 20.2%) vs 26% new low (max -10.7%) 5 Days Later: 81% new highs, 38% new lows Same Week: 56% broke 42 (+9%) $VRNS - Ref.Earnings: 18 Next Day: 33% new high (max 5.8%) vs 50% new low (max -8.5%) 5 Days Later: 39% new highs, 67% new lows Same Week: 50% broke 45 (+4%) https://aivelx.com #AivelX #AI #Python

User Image Estimize Posted - 6 days ago

$SWAV reports after the close, Estimize Consensus +0.02 EPS and +0.92M Revs compared to WS http://www.estimize.com/swav/fq1-2024?utm_content=prerelease&utm_medium=tweet&utm_source=stocktwits

User Image Subox Posted - 6 days ago

$SWAV will the stock be wiped out or it will continue trading as a separate entity?

User Image Isabel2019 Posted - 6 days ago

$SWAV anyone buying options ? Puts or calls?

User Image GalaxyBrainCapMgmmt Posted - 1 week ago

$SWAV looking

User Image intratio Posted - 1 week ago

$SWAV The mathematical model has forecasted that this company s stock price has an extremely bleak prognosis for the near future and is poised to drop further in the coming weeks

User Image Maverick11 Posted - 1 week ago

@The_Joker_has_Spoken I find it hilarious that me and others in this community are trying to make each other $ and you’re using up space posting nonsense. I have made nearly 3x in this name and shared 2-3 baggers here from $SMCI to $ARM to $SWAV and others. $OKLO will be another. Massive one. If you have something accretive and positive to share - do so. Otherwise, respectfully, go into the corner and self-fornicate. -Mav

User Image neiname Posted - 1 week ago

@AlphaRR agreed on $PTON and your analysis is great as usual. Stabilized and can only grow. Brand is strong and many loyal customers. Definite buyout candidate in the short to medium term. Wouldn’t be surprised if it was private equity as opposed to another tech company given Lina Khan’s heavy hand. Congrats on $SWAV although I think they had more to run. What are your thoughts on $SPT

User Image intratio Posted - 1 week ago

Shockwave Medical, Inc. Our engine is making the inference that this company s stock price will have a short-term downward trend and will be trending downward in the following months $SWAV

User Image intratio Posted - 1 week ago

https://www.intratio.com/stock-forecast/SWAV Shockwave Medical, Inc. Our trained model concludes this company s value will depreciate in the short-term and is not very optimistic about the future $SWAV

User Image intratio Posted - 04/27/24

https://www.intratio.com/stock-forecast/SWAV Our AI judges that the value of this equity has a negative short-term outlook and is anticipated to lose more during the next 90 days $SWAV

User Image shan116 Posted - 04/25/24

@Stockpicks1017 stock doesn’t work like that. If MM not sure about what happens with this stock , they ll be out of the stock as they have hell of lot of other stocks to play with. I did traded in the past like $SWAV and all will come into life based on some news doesn’t matter puts or calls.

User Image intratio Posted - 04/24/24

$SWAV https://www.intratio.com/stock-forecast/SWAV Our trained A.I. is making the inference that the price of this stock will decrease quickly and will have a negative trend in the upcoming months

User Image intratio Posted - 04/23/24

$SWAV https://www.intratio.com/stock-forecast/SWAV Shockwave Medical, Inc. The trained A.I judges this company s stock price has a bad setup for the short run and has a dismal outlook for the future

User Image TJmaximus Posted - 04/23/24

$SWAV

User Image intratio Posted - 04/23/24

https://www.intratio.com/stock-forecast/SWAV Shockwave Medical, Inc. The model has detected that the stock price of this company will not increase any time soon and has low expectations for the future $SWAV

User Image TJmaximus Posted - 04/22/24

$SWAV https://x.com/ShockwaveIVL/status/1782425186735992848

Analyst Ratings
CL King Neutral Apr 8, 24
Leerink Partners Market Perform Apr 8, 24
Deutsche Bank Hold Apr 8, 24
Morgan Stanley Equal-Weight Apr 8, 24
Canaccord Genuity Hold Apr 5, 24
Needham Hold Apr 5, 24
Wolfe Research Peer Perform Apr 5, 24
Piper Sandler Overweight Apr 2, 24
CL King Buy Mar 27, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
PUCKETT DAN Chief Financial Offi.. Chief Financial Officer Feb 05 Sell 230.7 3,229 744,930 21,005 02/06/24
PUCKETT DAN Chief Financial Offi.. Chief Financial Officer Feb 01 Sell 229.92 3,406 783,108 27,732 02/02/24
Zacharias Isaac President, CCO President, CCO Jan 26 Sell 224.69 4,000 898,760 63,920 01/29/24
Zacharias Isaac President, CCO President, CCO Jan 26 Option 6.71 4,000 26,840 67,920 01/29/24
Godshall Douglas Evan President & CEO President & CEO Jan 16 Sell 217.93 10,000 2,179,300 141,057 01/18/24
Godshall Douglas Evan President & CEO President & CEO Jan 16 Option 3.42 10,000 34,200 151,057 01/18/24
Zacharias Isaac President, CCO President, CCO Jan 12 Option 5.37 17,921 96,236 63,920 01/17/24
WATKINS FRANK T Director Director Jan 08 Sell 198.09 2,000 396,180 4,532 01/10/24
WATKINS FRANK T Director Director Jan 08 Option 3.42 2,000 6,840 6,532 01/10/24
Godshall Douglas Evan President & CEO President & CEO Jan 05 Sell 200.05 10,000 2,000,500 141,057 01/08/24
Godshall Douglas Evan President & CEO President & CEO Jan 05 Option 3.42 10,000 34,200 151,057 01/08/24
WATKINS FRANK T Director Director Jun 20 Option 3.416 3,000 10,248 4,532 01/04/24
Zacharias Isaac President, CCO President, CCO Dec 26 Sell 192.5 4,000 770,000 41,606 12/28/23
Zacharias Isaac President, CCO President, CCO Dec 26 Option 6.71 3,458 23,203 45,606 12/28/23
Godshall Douglas Evan President & CEO President & CEO Dec 15 Sell 188.79 5,000 943,950 141,057 12/18/23
Godshall Douglas Evan President & CEO President & CEO Dec 15 Option 3.42 5,000 17,100 146,057 12/18/23
PUCKETT DAN Chief Financial Offi.. Chief Financial Officer Dec 08 Sell 173.88 200 34,776 28,784 12/11/23
Phung Trinh VP, Finance VP, Finance Dec 07 Sell 171.63 203 34,841 29,037 12/08/23
Zacharias Isaac President, CCO President, CCO Nov 27 Sell 173.58 4,000 694,320 43,868 11/28/23
Zacharias Isaac President, CCO President, CCO Nov 27 Option 6.71 3,777 25,344 47,868 11/28/23
WATKINS FRANK T Director Director Nov 20 Sell 173.11 3,000 519,330 1,532 11/21/23
WATKINS FRANK T Director Director Nov 20 Option 3.42 3,000 10,260 4,532 11/21/23
Godshall Douglas Evan President & CEO President & CEO Nov 15 Sell 174.38 5,000 871,900 136,057 11/17/23
Godshall Douglas Evan President & CEO President & CEO Nov 15 Option 3.42 5,000 17,100 141,057 11/17/23
Phung Trinh VP, Finance VP, Finance Apr 26 Option 3.42 2,400 8,208 31,095 11/03/23
Zacharias Isaac President, CCO President, CCO Oct 26 Sell 210.25 4,000 841,000 44,316 10/30/23
Zacharias Isaac President, CCO President, CCO Oct 26 Option 6.71 411 2,758 48,316 10/30/23
WATKINS FRANK T Director Director Oct 20 Sell 203.14 3,000 609,420 1,532 10/23/23
WATKINS FRANK T Director Director Oct 20 Option 3.42 3,000 10,260 4,532 10/23/23
Godshall Douglas Evan President & CEO President & CEO Oct 16 Sell 199.71 10,000 1,997,100 141,649 10/17/23
Godshall Douglas Evan President & CEO President & CEO Oct 16 Option 3.42 10,000 34,200 151,649 10/17/23
Zacharias Isaac President, CCO President, CCO Sep 26 Sell 192.12 4,000 768,480 47,905 09/27/23
WATKINS FRANK T Director Director Sep 20 Sell 209.23 3,000 627,690 1,532 09/21/23
WATKINS FRANK T Director Director Sep 20 Option 3.42 3,000 10,260 4,532 09/21/23
Godshall Douglas Evan President & CEO President & CEO Sep 15 Sell 212.62 10,000 2,126,200 141,649 09/19/23
Godshall Douglas Evan President & CEO President & CEO Sep 15 Option 3.42 10,000 34,200 151,649 09/19/23
Phung Trinh VP, Finance VP, Finance Aug 29 Option 3.416 5,000 17,080 25,986 08/31/23
Zacharias Isaac President, CCO President, CCO Aug 25 Sell 204.98 4,000 819,920 52,446 08/29/23
Godshall Douglas Evan President & CEO President & CEO Aug 24 Sell 212.95 10,000 2,129,500 141,649 08/25/23
Godshall Douglas Evan President & CEO President & CEO Aug 24 Option 3.42 10,000 34,200 151,649 08/25/23
FRANCIS LAURA Director Director Aug 22 Sell 220.97 497 109,822 3,054 08/23/23
WATKINS FRANK T Director Director Aug 21 Sell 218.97 3,000 656,910 1,532 08/22/23
WATKINS FRANK T Director Director Aug 21 Option 3.42 3,000 10,260 4,532 08/22/23
Toyloy Sara Director Director Aug 15 Sell 223.64 100 22,364 3,673 08/16/23
Zacharias Isaac President, CCO President, CCO Jul 26 Sell 268.06 4,000 1,072,240 56,678 07/27/23
WATKINS FRANK T Director Director Jul 20 Sell 267.11 3,000 801,330 1,532 07/21/23
WATKINS FRANK T Director Director Jul 20 Option 3.42 3,000 10,260 4,532 07/21/23
Papiernik Antoine Director Director Jul 05 Option 17.00 17,381 295,477 22,662 07/06/23
Zacharias Isaac President, CCO President, CCO Jun 26 Sell 291.84 4,000 1,167,360 60,678 06/26/23
Phung Trinh VP, Finance VP, Finance Jun 22 Sell 295.91 62 18,346 21,101 06/26/23